GPs should not make decisions about treating patients with hypertension based on high readings of blood pressure they have taken, finds a study in this week's BMJ. Instead, researchers recommend the use of home measurements by the patient or repeated measurements by a nurse, to counter the 'white coat' effect.

The aim of the research was to assess various methods of measuring blood pressure. Eight doctors and three practice nurses participated in the research involving 200 patients.

The patients had either been newly diagnosed with high blood pressure or were already receiving treatment for their high blood pressure. They were all being considered for treatment changes based on clinical readings.

Blood pressure readings were repeatedly made by either a nurse, home measurement, ambulatory monitoring or by a doctor. The researchers found readings made by the doctors were high in comparison to those visited by the nurse or measured by the patients at home.

The authors conclude: "The 'white coat' effect is important in diagnosing and assessing control of hypertension in primary care and is not a research artefact. If ambulatory or home measurements are not available, repeated measurements by a nurse or the patient should result in considerable less unnecessary monitoring, initiation and changing of treatment. It is time to stop using high blood pressure readings by general practitioners to make decisions about treatment."

Overall the home measurement system performed significantly better than all other methods and was also preferred best by patients, they conclude.

'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
1-Aug-2002

Page: 1
Related medicine news :

1. White coat hypertension common among sleep apnea patients
2. UB begins groundbreaking study on net effect on patients of HIV treatments, other drugs
3. Alcohol relapse adversely affects 10-year liver transplant survival
4. Most adverse events in hospitalized children are preventable
5. Examination of possible conflicts of interest to influence look at suspected adverse drug reactions
6. Panel offers recommendations for monitoring adverse events from dietary supplements
7. Calcium channel blocker reduces adverse cardiovascular events in certain patients
8. Drug companies should disclose adverse events before licensing
9. Study documents adverse events of pneumococcal vaccine in children
10. Patient safety study provides first national estimate of adverse events in Canadian hospitals
11. Timing of adverse events in hospital patients